Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand-Reference-Cited by-同舟云学术

Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand

Published:2017-12-29 Issue:3 Volume:37 Page:406-413
ISSN:0959-5236
Container-title:Drug and Alcohol Review
language:en
Short-container-title:Drug and Alcohol Review

Author:

Rychert Marta¹^ORCID,Wilkins Chris¹,Parker Karl¹,Witten Karen¹

Affiliation:

1. SHORE & Whariki Research Centre; Massey University; Auckland New Zealand

Publisher

Wiley

Subject

Health (social science),Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dar.12655/fullpdf

Reference34 articles.

1. Explaining recent increases in students' marijuana use: impacts of perceived risks and disapproval, 1976 through 1996;Bachman;Am J Public Health,1998

2. Explaining the recent decline in cocaine use among young adults: further evidence that perceived risks and disapproval lead to reduced drug use;Bachman;J Health Soc Behav,1990

3. An historical perspective on health-risk awareness and unhealthy behaviour: cigarette smoking in the United States 1949-1981;Leidner;Health Expect,2015

4. The impact of cannabis decriminalisation in Australia and the United States;Single;J Public Health Policy,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk perception and risk aversion among people who use New Psychoactive Substances;International Journal of Drug Policy;2021-11

2. Evaluation of Applications to an Alcohol and Substance Dependence Treatment and Training Centre (AMATEM): Data from Adiyaman Province in 2017;Acibadem Universitesi Saglik Bilimleri Dergisi;2021-04-01

3. Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre;Clinical Toxicology;2020-11-06

4. How deaths can help clinicians and policy‐makers understand the risks of novel psychoactive substances;British Journal of Clinical Pharmacology;2020-01-14